Hybrida Farms has completed Costa Rica's first pharmaceutical-grade medical cannabis export to the European Union. The shipment departed Costa Rica on March 13, marking a defining milestone in the country's emerging cannabis export sector and broader international trade development.
The shipment was executed in full compliance with Costa Rica Law 10113, its implementing regulations, applicable international treaties, including the UN Single Convention on Narcotic Drugs, and all import requirements of the receiving EU member state. Hybrida Farms is a PROCOMER-registered exporter and an Esencial COSTA RICA Nation Brand licensee.
Hybrida Farms is Costa Rica's first and only dual licensed operator authorized for both THC medical cannabis and industrial hemp, with licenses from MAG, the Ministry of Health, and ICD. This represents the first successful international export of medical cannabis by a government-licensed Costa Rican operator.
"This milestone reflects what is possible when a country creates a legal pathway and operators commit to executing at the highest international standards. Costa Rica now has the opportunity to support and scale an industry that was built in good faith and proven through real export performance," said Hybrida Farms / Vantage Point Global in a statement.
"This export validates that Costa Rica can compete at the highest level of pharmaceutical cannabis production globally," Director of Cultivation Riley Shields said. "By combining controlled-environment precision with one of the most naturally optimal climates in the world, we've built a system that consistently delivers for European medical markets. This is not just a milestone for our company, it's a signal of what Costa Rica can produce on the global stage."
"As a Costa Rican rooted in agriculture, I am proud of this moment," Hybrida Farms President Jorge Luis Calderón Chaves said. "We did not set out simply to grow cannabis; we set out to grow trust. Every gram exported carries responsibility, because at the end of the supply chain is a patient who deserves safe, tested medicine."
For more information:
Hybrida Farms
Email: [email protected]
hybridafarm.com/
